AAGYLUR
- Product NDC
- 70709-102
- 11-digit product format
- 707090102
- Labeler code
- 70709
- Product ID
- 70709-102_97662326-3312-4ed1-9036-77e250e34cda
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Penicillamine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Cycle Pharmaceuticals Ltd.
- Application
- ANDA213293
- Marketing category
- ANDA
- Marketing start
- 2025-09-25
- Substance
- PENICILLAMINE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Antirheumatic Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- AAGYLUR
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PENICILLAMINE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GNN1DV99GX |
| Rxcui | 198070, 2723908 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70709-102-10 | AAGYLUR | 100 in 1 BOTTLE | CAPSULE | 100 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70709-102-10 | 70709010210 | 100 CAPSULE in 1 BOTTLE (70709-102-10) | 100 capsule | 2025-09-25 | No | No | Current |